Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reza Meshkani

Showing results (1-10 of 117) with videos related to

Pageof 12
Sort By:
Clinical Biochemistry|June 9, 2009
Hepatic insulin resistance, metabolic syndrome and cardiovascular diseaseReza Meshkani, Khosrow Adeli
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 30, 2016
Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complicationsReza Meshkani, Sanaz Vakili
Phytotherapy Research : PTR|August 27, 2025
Natural Products Targeting Ferroptosis in Type 2 Diabetes Mellitus and Its ComplicationsFarshad Niazpour, Reza Meshkani
Phytotherapy Research : PTR|April 4, 2025
Unlocking the Therapeutic Potential of Autophagy Modulation by Natural Products in Tackling Non-Alcoholic Fatty Liver DiseaseFarshad Niazpour, Reza Meshkani
Free Radical Biology & Medicine|October 13, 2015
SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cellsSattar Gorgani-Firuzjaee, Reza Meshkani
Acta Diabetologica|November 4, 2010
The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjectsReza Meshkani, Mehryar Zargari, Bagher Larijani
Heliyon|November 29, 2023
Resveratrol as a potential protective compound against skeletal muscle insulin resistanceArash Bahramzadeh, Kosar Bolandnazar, Reza Meshkani
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 25, 2026
Metformin-phytochemical combination therapy in metabolic dysfunction-associated steatotic liver disease: mechanistic insights and therapeutic potentialJamal Amri, Amin Karimpour, Reza Meshkani
Clinical Therapeutics|July 19, 2018
Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled TrialsMehdi Koushki, Nasrin Amiri Dashatan, Reza Meshkani
Biochemical and Biophysical Research Communications|June 14, 2014
Palmitate induces SHIP2 expression via the ceramide-mediated activation of NF-κB, and JNK in skeletal muscle cellsSattar Gorgani-Firuzjaee, Saeideh Ahmadi, Reza Meshkani
Pageof 12

Showing results (1-10 of 117) with videos related to

Sort By:
Pageof 12
Clinical Biochemistry|June 9, 2009
Hepatic insulin resistance, metabolic syndrome and cardiovascular diseaseReza Meshkani, Khosrow Adeli
Clinica Chimica Acta; International Journal of Clinical Chemistry|August 30, 2016
Tissue resident macrophages: Key players in the pathogenesis of type 2 diabetes and its complicationsReza Meshkani, Sanaz Vakili
Phytotherapy Research : PTR|August 27, 2025
Natural Products Targeting Ferroptosis in Type 2 Diabetes Mellitus and Its ComplicationsFarshad Niazpour, Reza Meshkani
Phytotherapy Research : PTR|April 4, 2025
Unlocking the Therapeutic Potential of Autophagy Modulation by Natural Products in Tackling Non-Alcoholic Fatty Liver DiseaseFarshad Niazpour, Reza Meshkani
Free Radical Biology & Medicine|October 13, 2015
SH2 domain-containing inositol 5-phosphatase (SHIP2) inhibition ameliorates high glucose-induced de-novo lipogenesis and VLDL production through regulating AMPK/mTOR/SREBP1 pathway and ROS production in HepG2 cellsSattar Gorgani-Firuzjaee, Reza Meshkani
Acta Diabetologica|November 4, 2010
The relationship between uric acid and metabolic syndrome in normal glucose tolerance and normal fasting glucose subjectsReza Meshkani, Mehryar Zargari, Bagher Larijani
Heliyon|November 29, 2023
Resveratrol as a potential protective compound against skeletal muscle insulin resistanceArash Bahramzadeh, Kosar Bolandnazar, Reza Meshkani
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 25, 2026
Metformin-phytochemical combination therapy in metabolic dysfunction-associated steatotic liver disease: mechanistic insights and therapeutic potentialJamal Amri, Amin Karimpour, Reza Meshkani
Clinical Therapeutics|July 19, 2018
Effect of Resveratrol Supplementation on Inflammatory Markers: A Systematic Review and Meta-analysis of Randomized Controlled TrialsMehdi Koushki, Nasrin Amiri Dashatan, Reza Meshkani
Biochemical and Biophysical Research Communications|June 14, 2014
Palmitate induces SHIP2 expression via the ceramide-mediated activation of NF-κB, and JNK in skeletal muscle cellsSattar Gorgani-Firuzjaee, Saeideh Ahmadi, Reza Meshkani
Pageof 12